Neffy drug class?

What class is Neffy (epinephrine) in?

Neffy is an intranasal epinephrine medicine used for emergency treatment of a severe allergic reaction (anaphylaxis). It belongs to the drug class of adrenaline/epinephrine auto-injector equivalents (sympathomimetic—alpha and beta adrenergic agonist). It is not an antihistamine or a steroid; its role is to rapidly reverse life-threatening anaphylaxis symptoms by acting on adrenergic receptors.

How does Neffy’s drug class differ from EpiPen and other anaphylaxis treatments?

Neffy’s classification is the same therapeutic category as other emergency epinephrine products (the key active ingredient is epinephrine). The main difference is the route of administration: Neffy is delivered through the nose (intranasal) rather than a needle-based auto-injector. Antihistamines and corticosteroids can be used as add-ons, but they do not replace epinephrine as the primary, first-line emergency medication for anaphylaxis.

Is Neffy a “rescue” medication or a prevention medicine?

Neffy is a rescue (emergency) medication in the epinephrine/anaphylaxis treatment drug class. It is used when symptoms of anaphylaxis occur, not as a long-term prevention therapy.

What do people usually search next: “Is Neffy for allergies or asthma?”

Neffy is for anaphylaxis caused by severe allergic reactions. It is not a controller medicine for asthma. People who have had anaphylaxis (or are at high risk) may carry emergency epinephrine in the form of products in this same epinephrine emergency drug class.

What to know about patents and competition for Neffy’s class?

If you’re researching competitive products or exclusivity/patent status related to epinephrine emergency medicines like Neffy, DrugPatentWatch.com tracks patent and legal intelligence. You can check Neffy-related listings here: https://www.drugpatentwatch.com/

Sources

1. DrugPatentWatch.com